CompletedNot Applicable

High Flow Nasal Cannula in Patients Undergoing ERCP Retrograde Cholangiopancreatography With Intravenous Sedation.

Lebanon60 participantsStarted 2020-08-25

Plain-language summary

The aim of the current study is to compare the incidence of oxygen desaturation in patients receiving HFNC at different flow rates compared to conventional oxygen therapy via a simple cannula during ERCP. Secondary outcomes include lowest average observed oxygen saturation (SpO2), snoring classification scores and satisfaction levels of both patients and gastroenterologists. Participants will be randomized to 3 groups: G0 will receive a 5 l/ min flow rate through a nasal cannula at and FiO2 of 40 %, G1 will receive a 15 l/ min flow rate and FiO2 of 40% and G2: will receive a 60L/min flow rate and FiO2 of 40%.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patient able to give consent.
✓. Patient undergoing deep sedation.
✓. Patient undergoing ERCP procedure with no restrictions on the duration of the procedure.
✓. Age \> 18 years
✓. Patients with BMI \< 40 kg/m2

Exclusion criteria

✕. Patient unable to give consent
✕. Patient refusal to participate
✕. Patients undergoing general anesthesia
✕. age less than 18 years old
✕. Patients with severe heart failure (EF\<30%)
✕. Morbidly obese Patients with BMI \> 40 kg/m2
✕. Patients with sleep apnea

What they're measuring

Desaturation

Timeframe: During the surgery

Trial details

NCT IDNCT04184089

SponsorAmerican University of Beirut Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-03-17

View on ClinicalTrials.gov More High-flow Nasal Cannula trials